Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach (PCa-MAP)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by Radboud University
Sponsor:
Collaborators:
Siemens AG
Mount Vernon Hospital
Multi-Imagem and CDPI, Rio de Janeiro, Brasil
Norwegian University of Science and Technology
University of California, Los Angeles
University Hospital, Ghent
Johns Hopkins University
Medical University of Vienna
University Health Network, Toronto
Heidelberg University
Information provided by (Responsible Party):
Radboud University
ClinicalTrials.gov Identifier:
NCT01138527
First received: June 4, 2010
Last updated: November 5, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)